 |
|
Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies
Oh Young Bang, Kyoung-Min Park, Dong Seop Jeong
J Stroke. 2023;25(2):199-213. Published online 2023 Mar 15 DOI: https://doi.org/10.5853/jos.2022.03552
|
|
Citations to this article as recorded by
 Ischaemic stroke in a patient with non-valvular atrial fibrillation (NVAF) despite non-vitamin K oral anticoagulant (NOAC) therapy
Simon Zhen, Fion Chu, Afek Kodesh, Jisoon Kim
BMJ Case Reports.2024; 17(1): e258761. CrossRef Acute Ischaemic Stroke in Patients Treated with Direct Oral Anticoagulants: Potential Causes, Clinical Characteristics, and Short-Term Outcomes
Katarzyna Sawczyńska, Ewa Włodarczyk, Aleksandra Pawlicka, Bartosz Kołodziejczyk, Paweł Wrona, Kamil Wężyk, Tomasz Homa, Paulina Sarba, Dominik Wróbel, Kaja Zdrojewska, Maria Sobolewska, Dawid Rolkiewicz, Agnieszka Slowik, Domenico Maria Mezzapesa
Stroke Research and Treatment.2024; 2024: 1. CrossRef Patent Foramen Ovale May Decrease the Risk of Left Atrial Thrombosis in Stroke Patients With Atrial Fibrillation
Minyoul Baik, Chi Young Shim, Seo-Yeon Gwak, Young Dae Kim, Hyo Suk Nam, Soyoung Jeon, Hye Sun Lee, Ji Hoe Heo
Journal of Stroke.2023; 25(3): 417. CrossRef A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation
Xiao-Yuan Zheng, Guang-Wei Feng, Jing Guo, Fen Xie, Xia Li, Ming-Zhu Zhang, Xiu-Fen Zhang, Xiu-Feng Wu, Yong-Juan Ding
Frontiers in Pharmacology.2023;[Epub] CrossRef
|